0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-03-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 08904203 2023-03-01 2024-02-29 08904203 2024-02-29 08904203 2023-02-28 08904203 2022-03-01 2023-02-28 08904203 2023-02-28 08904203 2022-02-28 08904203 bus:Director1 2023-03-01 2024-02-29 08904203 core:WithinOneYear 2024-02-29 08904203 core:WithinOneYear 2023-02-28 08904203 bus:Micro-entities 2023-03-01 2024-02-29 08904203 bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-29 08904203 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 08904203 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 08904203 bus:FullAccounts 2023-03-01 2024-02-29
COMPANY REGISTRATION NUMBER: 08904203
The International Radiology Reporting Group Limited
Filleted Unaudited Financial Statements
29 February 2024
The International Radiology Reporting Group Limited
Statement of Financial Position
29 February 2024
2024
2023
£
£
Fixed assets
1,141
1,525
-------
-------
Current assets
11,889
21,817
Creditors: amounts falling due within one year
81,696
74,874
--------
--------
Net current liabilities
69,807
53,057
--------
--------
Total assets less current liabilities
( 68,666)
( 51,532)
Accruals and deferred income
1,320
1,230
--------
--------
(69,986)
(52,762)
--------
--------
Capital and reserves
( 69,986)
( 52,762)
--------
--------
For the year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 5 November 2024 , and are signed on behalf of the board by:
Dr Sleiman Haddad
Director
Company registration number: 08904203
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is First Floor,, 6 Nelson Street,, Southend-On-Sea, Essex, SS11EF.